endece.comContact us
About company
ENDECE developed NDC-1308 a novel therapeutic that is anti-inflammatory and antiviral for acute respiratory distress syndrome ARDS and SARS-CoV-2 / COVID-19
US 1001 west glen
Unknown
Not verified company
ENDECE developed NDC-1308 a novel therapeutic that is anti-inflammatory and antiviral for acute respiratory distress syndrome ARDS and SARS-CoV-2 / COVID-19
